Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03632954 · ClinicalTrials.gov registry record
Cytal® Wound Matrix and MicroMatrix® Wound Study
A clinical trial, sponsored by Integra LifeSciences Corporation.
- Terminated
- Registry status
- 37
- Enrollment target
NCT03632954 is a clinical trial that was terminated before completion, run by Integra LifeSciences Corporation. The registered enrollment target is 37 participants.
The verdict
NCT03632954 was terminated before completion, sponsored by Integra LifeSciences Corporation.
- TERMINATED
- Registry status
- 37 participants
- Enrollment target
Study Summary
This is an observational study to assess the safety and efficacy of MicroMatrix® alone or in combination with Cytal® Wound Matrix on primary measures of wound healing.
Interventions
- DEVICE ACell Arm
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2018-12-11 |
| Est. Completion | 2020-01-27 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03632954
The ClinicalTrials.gov registry entry for NCT03632954 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Integra LifeSciences Corporation, which has 60 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ACell Arm is the first listed.
NCT03632954 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03632954 about?
NCT03632954 is a clinical study titled "Cytal® Wound Matrix and MicroMatrix® Wound Study". This is an observational study to assess the safety and efficacy of MicroMatrix® alone or in combination with Cytal® Wound Matrix on primary measures of wound healing.
What is the current status of trial NCT03632954?
This trial is currently terminated. The enrollment target is 37 participants. The study started on 2018-12-11. Estimated completion is 2020-01-27.
What interventions are being tested in trial NCT03632954?
The interventions under investigation include: ACell Arm (DEVICE).
Who is sponsoring clinical trial NCT03632954?
This trial is sponsored by Integra LifeSciences Corporation, which has 60 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.